Research And Markets Research And Markets
0 CHECKOUT

Vitiligo - Pipeline Review, H1 2015

  • ID: 3275725
  • May 2015
  • 55 pages
  • Global Markets Direct
1 of 4

Vitiligo - Pipeline Review, H1 2015

Summary

The‘Vitiligo - Pipeline Review, H1 2015’, provides an overview of the Vitiligo’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Vitiligo, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vitiligo and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that READ MORE >

Note: Product cover images may vary from those shown
2 of 4

List of Tables

List of Figures

Introduction

Report Coverage

Vitiligo Overview

Therapeutics Development

Pipeline Products for Vitiligo - Overview

Pipeline Products for Vitiligo - Comparative Analysis

Vitiligo - Therapeutics under Development by Companies

Vitiligo - Therapeutics under Investigation by Universities/Institutes

Vitiligo - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Vitiligo - Products under Development by Companies

Vitiligo - Products under Investigation by Universities/Institutes

Vitiligo - Companies Involved in Therapeutics Development

Ache Laboratorios Farmaceuticos S/A

Biocon Limited

Bristol-Myers Squibb Company

Clinuvel Pharmaceuticals Limited

Reliance Life Sciences Pvt. Ltd.

Sun Pharma Advanced Research Company Ltd.

Vitiligo - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

abatacept (recombinant) - Drug Profile

Product Description

Mechanism of Action

R&D Progress

ACH-24 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

afamelanotide - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Gene Therapy to Activate SOX9 for Vitiligo and Melanoma - Drug Profile

Product Description

Mechanism of Action

R&D Progress

itolizumab - Drug Profile

Product Description

Mechanism of Action

R&D Progress

ReliDerm-M - Drug Profile

Product Description

Mechanism of Action

R&D Progress

SUN-0597 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Vitiligo - Recent Pipeline Updates

Vitiligo - Dormant Projects

Vitiligo - Product Development Milestones

Featured News & Press Releases

Sep 19, 2014: SCENESSE vitiligo study results published in JAMA Dermatology

May 06, 2014: Clinuvel’s Phase II vitiligo study commences in Singapore

Dec 19, 2012: Clinuvel Pharma Announces Results From Phase IIa Pilot Study Of Scenesse In Vitiligo

Mar 02, 2011: Clinuvel Announces FDA Approval For Vitiligo Drug Trial

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

Number of Products under Development for Vitiligo, H1 2015

Number of Products under Development for Vitiligo - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Number of Products under Investigation by Universities/Institutes, H1 2015

Comparative Analysis by Clinical Stage Development, H1 2015

Comparative Analysis by Early Stage Development, H1 2015

Products under Development by Companies, H1 2015

Products under Investigation by Universities/Institutes, H1 2015

Vitiligo - Pipeline by Ache Laboratorios Farmaceuticos S/A, H1 2015

Vitiligo - Pipeline by Biocon Limited, H1 2015

Vitiligo - Pipeline by Bristol-Myers Squibb Company, H1 2015

Vitiligo - Pipeline by Clinuvel Pharmaceuticals Limited, H1 2015

Vitiligo - Pipeline by Reliance Life Sciences Pvt. Ltd., H1 2015

Vitiligo - Pipeline by Sun Pharma Advanced Research Company Ltd., H1 2015

Assessment by Monotherapy Products, H1 2015

Number of Products by Stage and Target, H1 2015

Number of Products by Stage and Mechanism of Action, H1 2015

Number of Products by Stage and Route of Administration, H1 2015

Number of Products by Stage and Molecule Type, H1 2015

Vitiligo Therapeutics - Recent Pipeline Updates, H1 2015

Vitiligo - Dormant Projects, H1 2015

List of Figures:

Number of Products under Development for Vitiligo, H1 2015

Number of Products under Development for Vitiligo - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Comparative Analysis by Clinical Stage Development, H1 2015

Comparative Analysis by Early Stage Products, H1 2015

Assessment by Monotherapy Products, H1 2015

Number of Products by Top 10 Targets, H1 2015

Number of Products by Stage and Top 10 Targets, H1 2015

Number of Products by Top 10 Mechanism of Actions, H1 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015

Number of Products by Top 10 Routes of Administration, H1 2015

Number of Products by Stage and Top 10 Routes of Administration, H1 2015

Number of Products by Top 10 Molecule Types, H1 2015

Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

- Ache Laboratorios Farmaceuticos S/A
- Biocon Limited
- Bristol-Myers Squibb Company
- Clinuvel Pharmaceuticals Limited
- Reliance Life Sciences Pvt. Ltd.
- Sun Pharma Advanced Research Company Ltd.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db